MX9102245A - Combinaciones de compuestos vainilloides y compuestos antivirales de nucleosido para el tratamiento de infecciones de herpes - Google Patents

Combinaciones de compuestos vainilloides y compuestos antivirales de nucleosido para el tratamiento de infecciones de herpes

Info

Publication number
MX9102245A
MX9102245A MX9102245A MX9102245A MX9102245A MX 9102245 A MX9102245 A MX 9102245A MX 9102245 A MX9102245 A MX 9102245A MX 9102245 A MX9102245 A MX 9102245A MX 9102245 A MX9102245 A MX 9102245A
Authority
MX
Mexico
Prior art keywords
compounds
vanylloid
combinations
treatment
antiviral nucleoside
Prior art date
Application number
MX9102245A
Other languages
English (en)
Spanish (es)
Inventor
Stanberry Lawrence Raymond
Brand Larry Milton
Floyd Benjamin Franklin
O'neill Timothy Peter
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX9102245A publication Critical patent/MX9102245A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX9102245A 1990-11-27 1991-11-27 Combinaciones de compuestos vainilloides y compuestos antivirales de nucleosido para el tratamiento de infecciones de herpes MX9102245A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61875790A 1990-11-27 1990-11-27

Publications (1)

Publication Number Publication Date
MX9102245A true MX9102245A (es) 1992-07-08

Family

ID=24479012

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102245A MX9102245A (es) 1990-11-27 1991-11-27 Combinaciones de compuestos vainilloides y compuestos antivirales de nucleosido para el tratamiento de infecciones de herpes

Country Status (7)

Country Link
EP (1) EP0559744A1 (fr)
JP (1) JPH06502865A (fr)
AU (1) AU9073691A (fr)
CA (1) CA2097087A1 (fr)
IE (1) IE914112A1 (fr)
MX (1) MX9102245A (fr)
WO (1) WO1992009287A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68918991T2 (de) * 1988-06-17 1995-04-27 Procter & Gamble Anwendung von Vanillin-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Herpes simplex-Infektion.

Also Published As

Publication number Publication date
EP0559744A1 (fr) 1993-09-15
WO1992009287A1 (fr) 1992-06-11
IE914112A1 (en) 1992-06-03
JPH06502865A (ja) 1994-03-31
AU9073691A (en) 1992-06-25
CA2097087A1 (fr) 1992-05-28

Similar Documents

Publication Publication Date Title
ES2138969T3 (es) Combinacion de nucleosidos antivirales.
DE69325333T2 (de) Antivirale Zusammensetzung
IT8847858A0 (it) Agenti per la profilassi e la terapia di infezioni retrovirali
CY1889A (en) Use of 3'-azido-3'-deoxythymidine in the treatment or prophylaxis of human retroviral infections
ES2186667T3 (es) Analogos de nucleosidos de 1,3-oxatiolano.
RU93045710A (ru) Противовирусная нуклеозидная композиция, способ ее получения и способ лечения
DE3780581D1 (de) Antiviralen phosphonomethoxyalkylen-purin- und -pyrimidin-derivate.
HK1002426A1 (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
FI940167A0 (fi) Puriinijohdannaisia
NO952508D0 (no) Purinderivater
NO995622D0 (no) Karbocyklisk nukleosidhemisulfat og anvendelse derav for behandling av virale infeksjoner
ATE71840T1 (de) Virushemmende nukleosidmischung.
AU9079491A (en) Combinations of vanilloid compounds and phosphonate antiviral compounds for treatment of herpes infections
PT876146E (pt) Analogos de nucleosidos em terapia de combinacao de infeccoes por herpes simplex
BR9509986A (pt) Uso de agentes antivirais aminopurina para o tratamento e profilaxia de infecções de vírus de herpes latentes
MX9102245A (es) Combinaciones de compuestos vainilloides y compuestos antivirales de nucleosido para el tratamiento de infecciones de herpes
EP0453247A3 (fr) Composés antivirals
ES554903A0 (es) Disposicion para el tratamiento de piezas de trabajo
ITMI912224A0 (it) Impiego di composti adenosinici nel trattamento dell'ischemia
PT100435A (pt) Nucleosidos terapeuticos
ITMI913464A1 (it) Procedimento per la neutralizzazione di perfluoropoliossialchileni
BR9406575A (pt) Método de combater infecçoes virais de herpes simplex aciclovir-resistentes
FI954348A (fi) Säädetysti vapauttava alumiinia sisältävä farmaseuttinen valmiste
ES2019583B3 (es) Composicion para el tratamiento de infecciones.
KR930701470A (ko) 누클레오시드의 인지질 유도체, 이것의 제조방법 및 항바이러스제로서의 사용